Status:
RECRUITING
Clinic-based Versus Hotspot-focused Active TB Case Finding
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Walimu
Conditions:
Tuberculosis, Pulmonary
Mycobacterium Tuberculosis Infection
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
This five-year study will evaluate two strategies for conducting tuberculosis (TB) active case finding (ACF) and linkage to TB treatment or TB preventive therapy (TPT) in peri-urban Uganda. The two st...
Eligibility Criteria
Inclusion
- Age ≥15 years, OR age 5-14 and a close contact of someone diagnosed with TB,
- Provision of oral informed consent, or, if age \<18 years and not legally emancipated, oral informed assent (if ages 8-17) and parental informed consent (ages 5-17) to participate in the study
- Ability to communicate with study staff in English or Luganda, or availability of a capable interpreter who is acceptable to the participant
Exclusion
- On treatment for, or diagnosed with but not yet treated for, active TB
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2027
Estimated Enrollment :
150000 Patients enrolled
Trial Details
Trial ID
NCT05285202
Start Date
June 1 2022
End Date
January 31 2027
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walimu
Kampala, Uganda